Carregant...

Expression of the K303R Estrogen Receptor α Breast Cancer Mutation Induces Resistance to an Aromatase Inhibitor via Addiction to the PI3K/Akt Kinase Pathway

Aromatase inhibitors (AIs) are rapidly becoming the first choice for hormonal treatment of estrogen receptor alpha (ERα)-positive breast cancer in postmenopausal women. However, de novo and acquired resistance frequently occurs. We have previously identified a lysine to arginine transition at residu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Barone, Ines, Cui, Yukun, Herynk, Matthew H, Corona-Rodriguez, Arnoldo, Giordano, Cinzia, Selever, Jennifer, Beyer, Amanda, Andò, Sebastiano, Fuqua, Suzanne A. W.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2804866/
https://ncbi.nlm.nih.gov/pubmed/19487288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-08-4194
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!